chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On the night they were big balls and it was itchy.; very little pimples or rash on body and legs, started appearing on arms and face too; arm started hurting, it hurt too much, it's still sensitive; headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (On the night they were big balls and it was itchy.), RASH (very little pimples or rash on body and legs, started appearing on arms and face too), VACCINATION SITE PAIN (arm started hurting, it hurt too much, it's still sensitive) and HEADACHE (headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic. Concomitant products included LEVOTHYROXINE for Hypothyroidism.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PRURITUS (On the night they were big balls and it was itchy.), RASH (very little pimples or rash on body and legs, started appearing on arms and face too), VACCINATION SITE PAIN (arm started hurting, it hurt too much, it's still sensitive) and HEADACHE (headache). At the time of the report, PRURITUS (On the night they were big balls and it was itchy.), RASH (very little pimples or rash on body and legs, started appearing on arms and face too), VACCINATION SITE PAIN (arm started hurting, it hurt too much, it's still sensitive) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event included Famotidine 20 mg, Dinfeniydramine and Prednisone tablets.   Reporter did not allow further contact
Shots given around lunchtime - mother says about 3 hours later - spiked temp - on & off until the day seen.  T max 103-104.  Decreased po intake.  No seizure activity - pt seen 3/19.  Admitted overnight at hospital, discharged 3/20.  Afebrile, good suck, good po tolerance.
Patient brought to the ED on 10/31 with generalized weakness that started the same morning. He lives at an assisted living facility, and the nurse checked his vitals and found that this heart was irregular so advised he come to the ED. Additionally the patient reported about 2 episodes of diarrhea per day for the past two weeks. In the ED, he was found to have a fever of 100.3 F and oxygen saturations at 88-90% on room air. He tested positive for COVID-19 by PCR. He was admitted to the hospital 10/31 - 11/3 for sepsis with COVID-19 infection resulting in acute diarrhea. Patient has received the primary vaccine series and two boosters.
10/27/21 SEEN  IN THE ER  FOR WITH COMPLAINTS OF 3 DAYS OF DRY COUGH,SOB, FEVER,  CHEST PAIN.OXYGEN SAT = 84% ON ROOM AIR. NOTED TO HAVE TACHYCARDIA. DX: WITH PNUEMONIA DUE TO COVID 19, RESP FAILURE.ADMITTED TO ICU.  PATIENT CONDITION CONTINUED TO WORSEN, REQUIRED HIGH FLOW BIPAP, INFLAMMATORY MARKERS CONTINUED TO PROGRESS. PATIENT DIED 11/8/2021
Information has been received from a medical assistant concerning a male pt greater than 65 yrs of age who was vaccinated with the second dose of pneumococcal 23v polysaccharide vaccine. It was reported that no other vaccinations were given with the pneumococcal 23v polysaccharide vaccine. The pt was reported as generally healthy with no major health problems. Subsequently, the pt developed injection site cellulitis which lasted at the most for 3 days. The pt recovered from the injection site cellulitis. No further information is available.
Itching in mouth around 30 to 40 minutes after shot administered, the rest of body itching for about 10 hours after. No impact to breathing, no hives visible.
Immediately following receiving the Menactra injection, patient's head became limp and I asked her to lay her head on my shoulder. She did not comply so I started to lay patient back on the exam table on which she was seated. As she was being laid back, she started either shaking  or seizing (I could not determine which). I sat her up again and she said, 'That was weird, what just happened?'. I explained that she had had an adverse reaction after her vaccine and asked her to lie back again, which she did. I then opened the exam room door and summoned the PCP, who came in the room immediately and examined the patient while she remained laying down. Her pulse and BP were taken and recorded. The patient was then given some water to drink. She stood without dizziness and was walked out to the waiting room to her sister, who had accompanied her to the office. She was asked to remain another 15 minutes and told she could leave at that time if no further reactions were noted.
MODERNA COVID VACCINE #3 GIVEN 11/8/21, LOT # 076C21A; pt had a positive COVID test and was hospitalized at a local health care facility on 2/5/22; dc'd to home (date not in medical records); 2/26/22 pt back to ED with increasing SOB, nausea, vomiting, generalized weakness; placed on NRB for hypoxia; hypotensive; DNR/DNI; given Rocephin; Sinus Tachycardia with right bundle branch block; pt became unresponsive prior to a test with agonal respirations; pt made comfortable and she passed away in the hospital
lymphadenopathy; Tiredness; Headache; Chills; Joint pain; Fever; injection site swelling; injection site redness; Feeling unwell; Muscle pain; Injection site pain, It is still tender today; This is a spontaneous report from a contactable consumer (patient). A 71-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0151) via an unspecified route of administration, administered in Arm Left on 08Apr2021 (at the age of 71-year-old) as dose 1, single for COVID-19 immunisation. Medical history included bursitis (she was treated with Cortisone) from 18Jan2021 to an unknown date, COVID-19 from Nov2020 to an unknown date. It was reported that she is still having ongoing issues from having Covid in Nov. She has horrible bursitis in both hips from recovering from Covid. This includes multiple joints, both hips, ankles, shoulder and wrist. Concomitant medication included paracetamol (TYLENOL) taken for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. History of all previous immunization with the Pfizer vaccine considered as suspect was reported as none. Additional vaccines administered on same date of the Pfizer Suspect was reported as none. Patient family medical history was reported as none. It was reported that She saw the doctor 28Dec2020. She was put on Valtaren because of multiple joint pain in her ankles, both hips, left shoulder and left wrist. The last set of labs she had drawn was in Dec 2020. She had a flu shot Oct2020. She still has ongoing symptoms. She has had head fog since prior to getting the vaccine, and after having Covid. On 08Apr2021 the patient experienced injection site pain it is still tender today, muscle pain, joint pain, fever, injection site swelling, injection site redness, feeling unwell. On 09Apr2021 tiredness, headache, chills. On 10Apr2021 lymphadenopathy. Patient was unable to state if muscle pain has resolved or is ongoing. Her legs are still very sore. The general muscle pain has improved. The chills were off and on through 15Apr2021.The lymph node is still tender. Outcome of the events injection site pain, tiredness, feeling unwell was recovering. Headache was recovered on 12Apr2021. Outcome of the events chills, fever, injection site redness was recovered on 15Apr2021. Outcome of the event injection site swelling was recovered on 18Apr2021 and Lymphadenopathy was recovered with sequelae on 17Apr2021. Outcome of the event muscle pain was unknown and joint pain was not recovered.  No Follow-up attempts completed. No further information is expected.
This spontaneous report as received from a consumer refers to his wife 76 years old female patient with high blood pressure, allergy to codeine and allergy to microdenton. The patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot number not provided) on an unknown date in 2009 "3 years ago". No other co-suspects were reported. There was high blood pressure medication as a concomitant medication. In November 2011 the patient had been diagnosed with bullous pemphigoid. The patient started taking high doses of steroids, prednisone to alleviate her symptoms. The patient's husband suspected that because the patient had the vaccine and was now taking steroids, there was a contraindication. He mentioned he would be contacting his health care professional . The patient sought unspecified medical attention. No laboratory diagnostics studies were performed. The outcome of bullous pemphigoid was unknown. Additional information has been requested.
BLOOD CLOTS; This spontaneous report received from a patient concerned a female of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot no. No concomitant medications were reported.  On an unspecified date, the patient experienced blood clots, and was hospitalized (date unspecified) for 3 to 4 weeks. Treatment medications (dates unspecified) included: Xarelto (Rivaroxaban). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clots was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0 20210614970-COVID-19 VACCINE AD26.COV2.S-blood clots. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Flushing/sweating, dizziness. BP 113/63 (pulse 92).
Fever:  102.1 F, headache, chills, nausea, digestive issues, joint aches, fatigue, swollen lymph nodes.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 71-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 26-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022).    No concomitant medication information was reported. Patient received half dose. The vial was initially stored in refrigerator on 04-Jun-2022. The vial did not undergo any temperature excursions. No treatment information was reported.
little swelling; Tenderness; boost of energy/felt rejuventaed; euphoric feeling; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (little swelling), TENDERNESS (Tenderness), ENERGY INCREASED (boost of energy/felt rejuventaed) and EUPHORIC MOOD (euphoric feeling) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced SWELLING (little swelling), TENDERNESS (Tenderness), ENERGY INCREASED (boost of energy/felt rejuventaed) and EUPHORIC MOOD (euphoric feeling). At the time of the report, SWELLING (little swelling), TENDERNESS (Tenderness), ENERGY INCREASED (boost of energy/felt rejuventaed) and EUPHORIC MOOD (euphoric feeling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
her arm was sore for 1 or 2 days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her arm was sore for 1 or 2 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (her arm was sore for 1 or 2 days). At the time of the report, PAIN IN EXTREMITY (her arm was sore for 1 or 2 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
PATIENT RECEIVED BOTH MODERNA AND SHINGRIX ON 02/27/2023. PATIENT RETURNED WITH LEFT ELBOW SWOLLEN WITH A VISABLE LUMP WHAT FELT LIKE FLUID FILLED. CHECKED THE INJECTION SITE AND NO REDNESS OR VISIBLE SKIN IRRITATION. PATIENT REPORTS NO PAIN BUT NOTICE BIGGER ELBOW ON THE EVENING OF 02/27/2023. I CALLED PATIENT 03/01/2023 TO GET AN UPDATE AFTER INSTRUCTING PATIENT TO APPLY HEAT AND TAKE AN nsaid. PATIENT DID NOT DO ANYTHING AND REPORTS NO CHANGE IN ELBOW.
was supposed to give a full dose but gave the half booster dose; This spontaneous case was reported by a health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (was supposed to give a full dose but gave the half booster dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (was supposed to give a full dose but gave the half booster dose). At the time of the report, ACCIDENTAL UNDERDOSE (was supposed to give a full dose but gave the half booster dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter.  No treatment information provided.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 30-JUN-2014, the patient was inadvertently vaccinated with a dose of PEDVAXHIB (lot#, expiration date, dose, route, strength and indication not reported). Additional vaccines that were given during the same visit were PENTACEL (lot#, expiration date, dose, route, strength and indication not reported), PREVNAR and ROTATEQ. Medical assistant said that the patient should not have received the PEDVAXHIB because the PENTACEL had a similar indication (Hib immunization). No symptoms reported. It was unspecified if the patient sought medical attention. Additional information is not expected.
Patient began having Dyspnea approximately 45 minutes after the varivax vaccine was administered.  After treatment with xopenex and prevacid patients symptoms resolved within approximately 1 hour.
Mother says history of loss of conscious after shots. My son fainted after receiving the vaccine for having looked at his brother who also fainted. Paramedics called 911 as brother became unconscious then patient also fell to ground was breathing normally - Paramedics treated paramedic took vitals
Dizziness; watery diarrhea; Booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 53 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 22Nov2021 18:00 (Lot number: FH8028) at the age of 53 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Graves Disease" (unspecified if ongoing). Concomitant medication(s) included: METHIMAZOLE. Past drug history included: Cipeo, reaction(s): "Known allergies". Vaccination history included: Bnt162b2 (Dose number: 1, Brand: Pfizer, Lot number: ER8733, Administration time: 03:00 PM, location: Right arm), administration date: 26Mar2021, when the patient was 52 years old, for COVID-19 Immunization; Bnt162b2 (Dose number: 2, Brand: Pfizer, Lot number: EW0162, Administration time: 05:00 PM, location: Right arm), administration date: 16Apr2021, when the patient was 53 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 22Nov2021 18:00, outcome "unknown", described as "Booster"; DIARRHOEA (non-serious) with onset 23Nov2021 18:00, outcome "recovering", described as "watery diarrhea"; DIZZINESS (non-serious) with onset 24Nov2021, outcome "recovering", described as "Dizziness". The events "watery diarrhea" and "dizziness" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of diarrhoea, dizziness.  Additional Information: Dizziness developed after two days. Severe explosive frequent watery diarrhea beginning 24 hours after the shot. Bright yellow complete liquid diarrhea.   Follow-up attempts are completed. No further information is expected.
Fever, chills, muscle aches, severe pain in arm where shot was given, lightheadedness, severe headache. Last from 03/22/2017 until 03/23/2017 around 5:00 PM.
Moderna Booster None @ first, next day developed hives on tongue and mouth. Headaches, chills, chest pains, no appetite, shortness of breath, Dizziness, vomiting, Had nausea before shot, anxiety, confusion, Weak feeling.
had hives all over body;h/a & no fever; 2 days p/vax;
onset of diffuse, pruritic rash.    Pathology:  psoriasiform dermatitis which worsened significantly following 2nd vaccination on 4/3/21
expired booster dose given to a patient; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired booster dose given to a patient) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 18-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired booster dose given to a patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired booster dose given to a patient) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant mediations were not reported Treatment information was not reported  The dose was administered more than 12 hours post puncture.    The HCP also reported the patient did not have any reaction to the expired dose   Reporter did not allow further contact
Patient woke at 1 am at night following the immunization the previous afternoon. Extreme chills - unable to talk. Muscle and joint pain - unable to get out of bed. Light sensitivity and dizzy  - stayed in a dark room. Unable to eat or drink. Brain fog. Stayed in bed the next day. Felt better the second day out and by the third was weak but was able to go out of the house.
This spontaneous report was received from a registered nurse and refers to a 30 year old patient of unknown gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 09-MAR-2016, the patient was inadvertently vaccinated with a dose of PROQUAD (Merck) (which had a lot # of L041629 and an expiration date of 22-APR-2017; however, dose, dosage number, route of administration and anatomical location were not reported). Additional information has been requested.
Immediate sensation to right hand (stiffening). Few hours later, pain in that hand and top of middle finger burned for 3 weeks.   Next few days, burning in feet, numbness in legs, more pain and weakness in both hands.  11/22/2021 saw an Internist and labs performed.  12/02/2021 saw a Neurologist.  12/13/2021 had nerve conduction test performed. Doctor advised second COVID-19 vaccine should not be administered since severe reaction occurred to my nerves.  It is unknown at this time if issue will resolve on its own.
Emesis on the night of injections 8 X 5 d temperature 102.5. The next day to 105.2 x 5 d within 24 hours. Motrin prn for increased temperature. Rash occurred two weeks later, Also cranky and tired
About 12 hours after the second Covid vaccine, I woke up with chills and severe body ache.  When I got up, I experienced a vasovagal syncope.  Mild fever, chills and body ache lasted for about 24 hours and resolved fairly suddenly.  Only one syncope event.
Muscles Pain (whole body). Join Pain (whole body). Join restriction        (Hands, Arms, and Legs both sides). Dificulties to get up and down stairs. Teeth pain.
Patient experienced hoarseness and swelling of throat and headache. Gave her 100mg of diphenhydramine and monitored her BP then sent her to the ER.
No adverse effects were reported; Was administered a dose of imporperly stored vaccines; This spontaneous report was received from a Certified Medical Assistant, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided.      On 09-JUL-2019, the patient was vaccinated with improperly stored doses of hepatitis a vaccine, inactivated (VAQTA) lot # R035227 expiration date on 01-JAN-2020 and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live  recombinant human albumin (rHA) (M-M-R II) lot # R031681 expiration date on 01-NOV-2020 (route of vaccination, strength and dose number were not provided) for prophylaxis.  It was stated that, the Hepatitis A Vaccine, Inactivated(VAQTA) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live rHA (M-M-R II), were exposed to a temperature excursion of above 47°F (92.3°F) for 13 hours 11 minutes and above 47°F (73°F) for 9 hours. The vaccines were not involved in any previous temperature excursion, and report was made due to a data logger. No adverse effects were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA012632: US-009507513-1907USA012633: US-009507513-1907USA012635: US-009507513-1907USA005377:
Gave shot to tricep area; red & inflammed on 15th, 6 inches in diameter & gave DPH, did nothing, cont DPH & gave Prenazone; On 20th gone; has tickling sensation on hand;